Jcog0405
WebPatients received two or three cycles of preoperative chemotherapy of irinotecan plus cisplatin in JCOG0001, or S-1 plus cisplatin in JCOG0405, followed by D3 gastrectomy. … Web1 feb 2011 · An integrated analysis of two phase II trails (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer (GC) with …
Jcog0405
Did you know?
Web過去の臨床試験. HOME ＞ 臨床試験報告 ＞ 過去の臨床試験. 【JCOG9501】. 大動脈周囲リンパ節郭清の臨床的意義に関する研究. 【JCOG9502】. 食道浸潤胃がんの外科治療に関する比較臨床試験. 【JCOG0001】. 高度リンパ節転移を伴う進行胃がんに対する術 … Gastric cancer is the second most common malignancy in the world, and surgical resection remains a vital part of curative treatment for most patients despite recent advances in chemotherapy1,2. Cure is attained by complete resection of the primary tumour and regional lymph nodes (R0 resection)3. The … Visualizza altro Data handling was performed by the JCOG Data Centre. The study protocol was approved by the Clinical Trial Review Committee of the JCOG and the institutional review board at each participating … Visualizza altro The authors thank other members of JCOG Stomach Cancer Study Group: T. Sano (Cancer Institute Hospital of the Japanese Foundation for Cancer Research, … Visualizza altro Between February 2005 and June 2007, 53 patients entered the study from 19 institutions. Follow-up was performed for 5 years after the … Visualizza altro This multi-institutional phase II trial of neoadjuvant chemotherapy followed by surgery with PAN dissection (JCOG0405) achieved much … Visualizza altro
Web5 mar 2024 · JCOG conducted another phase II study to evaluate the efficacy and safety of the preoperative chemotherapy with S-1 + cisplatin, which was the same regimens as …
WebWe previously reported the safety and efficacy of cisplatin and S-1 (CS) followed by D2 gastrectomy with PAN dissection for this target (JCOG0405, Br J Surg 2014). http://www.jcog.jp/document/0405.pdf
WebThe 3-year and 5-year survival rates in the JCOG1002 study were 62.7% and 54.9%, respectively, which were similar to those in the JCOG0405 study. At present, the standard therapy for these patients in Japan is still that stated in the JCOG0405 protocol. All three studies (JCOG0001, JCOG0405 and JCOG1002) combined PCT with D2 gastrectomy …
Web23 apr 2012 · However, an integrated analysis of JCOG0001 and JCOG0405 showed a greater therapeutic index (multiplication of frequency of lymph nodes metastasis by a 3-year survival rate) of para-aortic lymph node than JCOG9501 even in patients with bulky lymph node without para-aortic lymph node preoperatively (JCOG0001: 4.3, JCOG0405: 12, … granite title companyWeb16 giu 2016 · Background: Gastric cancer with extensive lymph node metastasis is commonly considered unresectable, with a poor prognosis. We previously reported the … granite titleWeb3 set 2013 · Patient population. We included all eligible patients from two clinical trials (JCOG0210 and JCOG0405) that were conducted by the JCOG. These phase II trials aimed to evaluate the efficacy and safety of neoadjuvant S-1 plus cisplatin in gastric cancer patients [7, 8].The eligibility criteria of the JCOG0210 trial included linitis plastica … granite tombstone cleanerWeb2 set 2024 · For patients with bulky N2 and PAN metastases, the 3-year and 5-year OS rates were 7.4% and 0.0%, respectively, which were lower than those of the JCOG0405 study (20.0% and 20.0%). Conclusion: The results of our study suggest that D2 lymphadenectomy alone is suitable for GC patients with only bulky N2 metastasis after … granite tombstone black monuments gravestoneWeb21 mar 2024 · An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis. Hiroshi Katayama. Akira Tsuburaya. Mitsuru Sasako. chinon roseWeb3 set 2013 · Patient population. We included all eligible patients from two clinical trials (JCOG0210 and JCOG0405) that were conducted by the JCOG. These phase II trials … granite tiles for wallWeb12 set 2024 · The RR was 64.7% in the JCOG0405, and the efficacy of DCS therapy was expected to be superior to that of CS therapy in the JCOG0405. The sample size was calculated to be 50 cases, under the hypothesis that the expected RR and threshold RR were 80% and 65%, respectively, with use of one-sided testing at the 10% significance … chinon rive gauche